Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Early postnatal NMDA receptor ablation in cortical interneurons impairs affective state discrimination and social functioning
    Published on 2025-01-19
    11 months ago
  • Polygenic overlap with granulocyte counts identifies novel loci for clozapine metabolism and clozapine-induced agranulocytosis
    Published on 2025-01-17
    11 months ago
  • Examining memory reconsolidation as a mechanism of nitrous oxide’s antidepressant action
    Published on 2025-01-16
    11 months ago
  • In memoriam: Dr. Thomas Lehner
    Published on 2025-01-13
    11 months ago
  • The impact of ovulation-suppressing contraceptives on behavioral and functional difficulties in borderline personality disorder
    Published on 2025-01-10
    11 months ago
  • Multivariate patterns among multimodal neuroimaging and clinical, cognitive, and daily functioning characteristics in bipolar disorder
    Published on 2025-01-08
    11 months ago
  • Epac2 activation drives calcium permeable-AMPA receptor accumulation, fueling the incubation of cocaine craving
    Published on 2025-01-06
    11 months ago
« Previous 1 … 32 33 34 35 36 … 143 Next »
Journal of Psychopharmacology
  • The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms
    Published on 2024-06-03
    2 years ago
  • Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights
    Published on 2024-05-28
    2 years ago
  • Changes in processing speed during early abstinence from alcohol dependence
    Published on 2024-05-28
    2 years ago
  • Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)
    Published on 2024-05-14
    2 years ago
  • Aripiprazole for treating delirium: A systematic review—Is it a valid yet understudied treatment?
    Published on 2024-04-30
    2 years ago
  • Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice
    Published on 2024-04-29
    2 years ago
  • Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database
    Published on 2024-04-28
    2 years ago
« Previous 1 … 32 33 34 35 36 … 134 Next »
European Neuropsychopharmacology
  • Challenges in testing concentrated cognitive-behaviour therapy for unmedicated adults with obsessive-compulsive disorder in routine care
    Published on 2024-04-21
    2 years ago
  • Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents
    Published on 2024-04-21
    2 years ago
  • Taking uncertainty in the assessment of response into account: An advanced guideline for computing responder rates in clinical trials
    Published on 2024-04-21
    2 years ago
  • Schizophrenia patients are not benefiting from worldwide improvements in life expectancy
    Published on 2024-04-21
    2 years ago
  • Cognitive screening in bipolar disorder
    Published on 2024-04-21
    2 years ago
  • Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
    Published on 2024-04-21
    2 years ago
  • Pre-existing chronic physical morbidity and excess mortality in people with bipolar disorder: A population-based cohort study in 2008–2018
    Published on 2024-04-21
    2 years ago
« Previous 1 … 32 33 34 35 36 … 153 Next »

   Pharma Pub